1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends

Antidiabetics Market Analysis By Product (Insulin, Biguanides, Thiazolodinediones, GLP-agonists, Sulphonylureas, DPP-4 inhibitors, SGLT-2, Alpha-glucosidase Inhibitors, Meglitinides) And Segment Forecasts To 2020

  • May 2016
  • 75 pages
  • Grand View Research
Report ID: 3340577

Summary

Table of Contents

Global antidiabetics market is expected to reach USD 84.13 billion by 2020. Growing prevalence of diabetes is the primary driver of this market. Growth in prevalence of disease causing lifestyle disorders such as irregular dietary habits and obesity is also expected to boost product demand by triggering incidence rates of target diseases. Future commercialization of products currently in the pipeline and the presence of large untapped opportunities in the emerging Asia Pacific and Latin American markets is expected to fuel future market growth.

Insulin was the most revenue generating segment and its market was valued at over USD 20.0 billion in 2013. Insulin is also one of the most lucrative segments of this market. Introduction of new products exhibiting higher efficacy coupled with the presence of favorable government initiatives are some factors attributing to its market attractiveness.

Further key findings from the study suggest:

Long acting insulin was the leading product segment in 2013 and is expected to grow at the CAGR of over 15.0% during the forecast period. The introduction of advanced products, high prices associated with these products and the phasing out of human insulin are some key factors attributing for its large share.
Rapid uptake of newly approved DPP-4 inhibitors such as Januvia, Nesina and Onglyza on account of their once daily dosage regimens and safety profiles catalyzed the growth of this market.
North America was the most matured antidiabetics market in 2013 accounting for over 43.0% of the market High market penetration of insulin and other antidiabetics and the presence of sophisticated reimbursement framework are expected to drive regional market growth.
Asia Pacific is expected to present manufacturers with lucrative future growth opportunities. Large presence of unmet patient needs and rapidly improving healthcare infrastructure are some factors expected to drive market growth in the region. The market is also expected to be driven by the introduction of cheaper products made available by local manufacturers.
Some key market players of antidiabetics include Sanofi Aventis, Takeda Pharmaceuticals, Eli Lilly, Oramed Pharmaceuticals Inc., Merck & Co. Inc., Novo Nordisk, Bristol-Myers Squibb, Halozyme Therapeutics and Pfizer.
The market is oligopolistic in nature with few players accounting for over 70% of the market. Extensive R&D investments aimed at new product development and entering new markets via government contracts are the key sustainability strategies adopted by these organizations.
For the purpose of this study, Grand View Research has segmented the global antidiabetics market on the basis of product and region:

Global Insulin Product Outlook (Revenue, USD Million, 2012 – 2020)
- Rapid acting
- Long acting
- Premixed
- Premixed analog
- Short acting
- Intermediate acting
Global Antidiabetics Product Outlook (Revenue, USD Million, 2012 – 2020)
- Alpha-glucosidase inhibitors
- Biguanides
- Sulphonylureas
- GLP-1 agonist
- Meglitinides
- DPP-4 inhibitors
- SGLT – 2
- Thiazolodinediones
Antidiabetics Regional Outlook (Revenue, USD Million, 2012 – 2020)
- North America
- Europe
- Asia Pacific
- RoW

Please note: this report requires certain updates. We have all the information available but require 2 working days business days to complete the process and ensure it is as up-to-date as possible.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Endothelial Dysfunction Global Clinical Trials Review, H2, 2017

  • $ 2500
  • Industry report
  • August 2017
  • by GlobalData

Endothelial Dysfunction Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Endothelial Dysfunction Global Clinical Trials Review, H2, 2017" provides an overview of ...

Global Diabetes Drugs Market 2017-2027

  • $ 3247
  • Industry report
  • July 2017
  • by Visiongain

Insulin and Insulin Analogues, DPP-4 Inhibitors, Biguanides, GLP-1 Agonists, Alpha-glucosidases, SGLT-2 Inhibitors, Sulfonylureas and Others The global diabetes drugs market was valued at $49.26bn in 2016 ...

The 2018-2023 World Outlook for Insulins and Anti-diabetic Hormones and Synthetic Substitute Pharmaceuticals

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for insulins and anti-diabetic hormones and synthetic substitute pharmaceuticals across more than 190 countries. For each year reported, estimates are given for the ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market

  • September 2017
    12 pages
  • Therapy  

    Therapy  

View report >

Therapy Market in the US

  • September 2017
    9 pages
  • Therapy  

  • United States  

View report >

Health Services Industry in the US

  • September 2017
    12 pages
  • Surgery  

    Stretcher  

    Hospital  

  • United States  

View report >

Related Market Segments :

Antidiabetics

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.